Previous 10 | Next 10 |
Oncolytics Biotech® Announces Abstract Publication and Upcoming Oral Presentation at the 2020 Society of Neuro-Oncology Annual Meeting - Data from a phase 1b, investigator-sponsored study show that a pelareorep-based combination therapy is safe and well-tolerated in newly d...
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Operational Highlights PR Newswire SAN DIEGO and CALGARY, AB, Nov. 6, 2020 - Conference call and webcast to take place on Wednesday, November 11, 2020 at 5:00 pm E...
Universal Security Instruments (UUU) +87%.Cellect Biotechnology (APOP) +36%.Pinterest (PINS) +31% on Q3 results.Inphi Corporation (IPHI) +27% as the company will be acquired by Marvell in a cash and stock transaction.Xtant Medical Holdings (XTNT) +22% on Q3 resul...
Palm Beach, FL –October 27, 2020 – Every year, the number of cancer-related deaths caused due to gastric cancer has been reaching to more than 800,000, as per the records of the World Health Organization. In the recent past, the number of people diagnosed with gastric cancer w...
1847 Goedeker (GOED) +81% on announcing agreement for the acquisition of Appliances Connection.SPI Energy (SPI) +40%.Sunworks (SUNW) +17%.Xilinx (XLNX) +13% as AMD to acquire the company in an all-stock transaction valued at $35B.Neptune Wellness Solutions (NEPT) +13% ...
Oncolytics Biotech (ONCY) launches a new multi-indication gastrointestinal ((GI)) cancer study to be managed by AIO, an academic cooperative medical oncology group based in Germany.The phase 1/2 trial, known as GOBLET, will investigate the use of pelareorep, in combination with Roche's (...
Oncolytics Biotech® Collaborates with Roche and AIO to Initiate a Phase 1/2 Gastrointestinal Cancer Trial Combining Pelareorep with Roche's Anti-PD-L1 Checkpoint Inhibitor PR Newswire SAN DIEGO, CA and CALGARY, AB, Oct. 27, 2020 Multi-center trial to assess th...
FN Media Group Presents USA News Group News Commentary Vancouver, BC – October 22, 2020 – USA News Group – It’s been a year and a half since the US Food and Drug Administration approved the first targeted immunotherapy in the treatment...
Would You Buy These Penny Stocks Based On Analyst Ratings? Penny stocks are some of the fastest moving names in the stock market. It might be stocks under 10 cents or a $4 stock. Whatever the case may be, traders buy and sell these with a simple goal, which is to make quick mone...
Oncolytics Biotech® Appoints Richard Vile, Ph.D., to its Scientific Advisory Board World-renowned scientist specializing in oncolytic viruses and immuno-oncology PR Newswire SAN DIEGO and CALGARY, AB, Oct. 19, 2020 SAN DIEGO and CALGARY, AB , Oct. ...
News, Short Squeeze, Breakout and More Instantly...
Oncolytics Biotech Inc. Company Name:
ONCY Stock Symbol:
NASDAQ Market:
Oncolytics Biotech Inc. Website:
Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program Canada NewsWire Clear path forward on key elements of the planned potential registration-enabling trial in HR+/HER2- metastatic breast cancer On track to report ove...
Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence Canada NewsWire Wayne Pisano , Chair of Oncolytics' Board of Directors, to serve as interim CEO Overall Survival data from BRACELET-1 breast ca...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...